HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Charles P France Selected Research

Quinpirole

8/2014Eating high fat chow and the behavioral effects of direct-acting and indirect-acting dopamine receptor agonists in female rats.
12/2011Drinking sucrose enhances quinpirole-induced yawning in rats.
12/2011Eating high fat chow increases the sensitivity of rats to 8-OH-DPAT-induced lower lip retraction.
10/2011Influence of body weight and type of chow on the sensitivity of rats to the behavioral effects of the direct-acting dopamine-receptor agonist quinpirole.
10/2010Eating high-fat chow increases the sensitivity of rats to quinpirole-induced discriminative stimulus effects and yawning.
1/2010Dopamine D3 receptors mediate the discriminative stimulus effects of quinpirole in free-feeding rats.
5/2009High fat diet and food restriction differentially modify the behavioral effects of quinpirole and raclopride in rats.
4/2009Some effects of dopamine transporter and receptor ligands on discriminative stimulus, physiologic, and directly observable indices of opioid withdrawal in rhesus monkeys.
9/2008Feeding conditions differentially affect the neurochemical and behavioral effects of dopaminergic drugs in male rats.
3/2007Insulin replacement restores the behavioral effects of quinpirole and raclopride in streptozotocin-treated rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Charles P France Research Topics

Disease

16Substance-Related Disorders (Drug Abuse)
10/2021 - 03/2007
16Pain (Aches)
12/2020 - 04/2011
12Opioid-Related Disorders (Opiate Addiction)
01/2022 - 09/2003
10Body Weight (Weight, Body)
11/2019 - 06/2006
9Hypothermia
01/2018 - 04/2009
8Shock
02/2014 - 03/2002
8Catalepsy
05/2009 - 01/2004
5Obesity
11/2018 - 05/2009
4Cocaine-Related Disorders (Cocaine Addiction)
01/2016 - 01/2008
3Respiratory Insufficiency (Respiratory Failure)
01/2021 - 01/2019
3Opiate Overdose
01/2021 - 01/2019
3Ataxia (Dyssynergia)
02/2012 - 06/2005
3Narcolepsy
08/2008 - 01/2004
2Insulin Resistance
08/2014 - 10/2011
2Central Nervous System Diseases (CNS Diseases)
05/2012 - 10/2010
2Feeding and Eating Disorders (Eating Disorder)
09/2008 - 03/2007
1Drug Overdose
01/2022
1Acute Pain
02/2017
1Chronic Pain
02/2017
1Hallucinations (Hallucination)
11/2013
1Night Terrors (Sleep Terror)
11/2013
1Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
10/2013

Drug/Important Bio-Agent (IBA)

23Opioid Analgesics (Opioids)IBA
01/2022 - 04/2011
15Pharmaceutical PreparationsIBA
01/2020 - 01/2004
10QuinpiroleIBA
08/2014 - 03/2007
9mu Opioid Receptors (mu Opioid Receptor)IBA
11/2020 - 01/2013
8Morphine (MS Contin)FDA LinkGeneric
11/2019 - 08/2007
7Serotonin (5 Hydroxytryptamine)IBA
01/2021 - 06/2009
7CannabinoidsIBA
01/2020 - 06/2013
7Cocaine (Cocaine HCl)IBA
02/2019 - 01/2008
6methocinnamoxIBA
01/2022 - 01/2019
6lorcaserinIBA
10/2021 - 12/2015
6Opioid Receptors (Opioid Receptor)IBA
01/2020 - 12/2012
6Cannabinoid Receptor AgonistsIBA
08/2018 - 12/2012
5Naloxone (Narcan)FDA LinkGeneric
01/2021 - 03/2010
4Fentanyl (Sublimaze)FDA LinkGeneric
01/2022 - 01/2021
4Naltrexone (ReVia)FDA LinkGeneric
01/2019 - 04/2007
4Dopamine (Intropin)FDA LinkGeneric
01/2016 - 09/2008
4Amphetamine (Amfetamine)FDA LinkGeneric
10/2013 - 03/2007
4GABA-B ReceptorsIBA
05/2012 - 06/2005
4Dizocilpine Maleate (Dizocilpine)IBA
08/2008 - 01/2004
4N-Methylaspartate (NMDA)IBA
08/2008 - 01/2004
4gamma-Aminobutyric Acid (GABA)IBA
08/2008 - 03/2002
3Narcotic Antagonists (Opioid Antagonists)IBA
01/2022 - 01/2019
3Heroin (Diamorphine)IBA
01/2022 - 01/2019
3Buprenorphine (Subutex)FDA LinkGeneric
10/2021 - 09/2003
3Serotonin ReceptorsIBA
01/2016 - 04/2011
3Insulin (Novolin)FDA Link
10/2011 - 03/2007
3BaclofenFDA LinkGeneric
10/2010 - 06/2005
3RacloprideIBA
05/2009 - 03/2007
3Sodium Oxybate (gamma Hydroxybutyrate)FDA Link
08/2008 - 01/2004
2Methadone (Dolophine)FDA LinkGeneric
01/2019 - 01/2008
25-HT2C Serotonin ReceptorIBA
11/2018 - 12/2015
2spiradolineIBA
01/2018 - 02/2017
25-HT2A Serotonin Receptor (5 HT2A Receptor)IBA
01/2016 - 01/2013
2Sucrose (Saccharose)IBA
08/2015 - 12/2011
2Midazolam (Versed)FDA LinkGeneric
01/2014 - 01/2013
28-Hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT)IBA
12/2011 - 06/2009
2Dopamine Agonists (Dopamine Agonist)IBA
10/2011 - 09/2008
2GABA-B Receptor AntagonistsIBA
10/2010 - 06/2005
2KetamineFDA LinkGeneric
08/2008 - 01/2004
2Blood Glucose (Blood Sugar)IBA
02/2008 - 03/2007
2Streptozocin (Streptozotocin)FDA Link
02/2008 - 07/2005
24-hydroxybutyric acidIBA
03/2007 - 07/2005
2Haloperidol (Haldol)FDA LinkGeneric
07/2005 - 01/2004
2N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
07/2005 - 01/2004
1carfentanil (carfentanyl)IBA
01/2022
1CyclodextrinsIBA
01/2021
1nalmefene (Revex)FDA Link
01/2021
1Proteins (Proteins, Gene)FDA Link
01/2020
1Ether (Diethyl Ether)IBA
01/2020
1OREX-1019IBA
01/2020
1kappa Opioid Receptors (kappa Opioid Receptor)IBA
01/2018
1Etorphine (M99)IBA
01/2018
13- (2- hydroxy- 4- (1,1- dimethylheptyl)phenyl)- 4- (3- hydroxypropyl)cyclohexanolIBA
02/2017
1Fish OilsIBA
08/2016
1Therapeutic UsesIBA
12/2015
1SugarsIBA
08/2015
1Flumazenil (Romazicon)FDA LinkGeneric
01/2014
1Pregnanolone (Allopregnanolone)IBA
01/2014
1efavirenz (Sustiva)FDA Link
11/2013
1ProdrugsIBA
10/2013
1Methylphenidate (Ritalin)FDA LinkGeneric
10/2013
1Lysine (L-Lysine)FDA Link
10/2013
1Modafinil (Provigil)FDA Link
10/2013
1Lisdexamfetamine DimesylateFDA Link
10/2013
1(3R)- ((2,3- dihydro- 5- methyl- 3- ((4- morpholinyl)methyl)pyrrolo- (1,2,3- de)- 1,4- benzoxazin- 6- yl)(1- naphthalenyl))methanone (WIN 55,212)IBA
06/2013
1Dronabinol (THC)FDA LinkGeneric
12/2012
1ApomorphineFDA Link
07/2012
12,6- di- tert- butyl- 4- (3- hydroxy- 2,2- dimethylpropyl)phenolIBA
10/2010
1arginine methyl esterIBA
10/2010
1(R,S)- 5,7- di- tert- butyl- 3- hydroxy- 3- trifluoromethyl- 3H- benzofuran- 2- oneIBA
10/2010
1AcidsIBA
10/2010
1Nitric Oxide Synthase (NO Synthase)IBA
10/2010

Therapy/Procedure

4Self Administration (Administration, Self)
11/2020 - 04/2016
3Drug Therapy (Chemotherapy)
11/2018 - 02/2016
3Induced Hypothermia
10/2010 - 05/2009
1Secondary Prevention
01/2020
1Analgesia
08/2018
1Therapeutics
01/2018